A systematic analysis of diagnostic performance for Alzheimer's disease using structural MRI
Jiangping Wu1, Kun Zhao2, Zhuangzhuang Li1
1School of Artificial Intelligence, Beijing University of Posts and Telecommunications, Beijing, 100876, China.
Psychoradiology
|April 26, 2024
Summary
Structural MRI shows promise for diagnosing Alzheimer's disease (AD). However, variations in datasets, models, and methods create heterogeneity, hindering clinical application of these diagnostic tools.
Area of Science:
- Neuroimaging
- Medical Informatics
- Geriatric Medicine
Background:
- Alzheimer's disease (AD) is a prevalent neurodegenerative disorder in the elderly population.
- Structural magnetic resonance imaging (sMRI) studies have achieved high accuracy (80-95%) in distinguishing AD from normal controls (NCs).
- Clinical translation of these diagnostic models into practical computer-aided diagnosis (CAD) systems for AD remains limited.
Purpose of the Study:
- To identify factors impeding the clinical adoption of sMRI-based diagnostic models for Alzheimer's disease.
- To systematically review and analyze existing diagnostic models for AD using sMRI.
Main Methods:
- A systematic literature review of sMRI-based AD diagnostic models published in the last 15 years.
- Inclusion of 101 studies based on predefined screening criteria.
- Evaluation of heterogeneity and publication bias using subgroup analysis, meta-regression, and statistical tests (Begg's, Egger's).
Main Results:
- Recently published studies show high diagnostic accuracy for AD detection using sMRI.
- Significant heterogeneity was observed across studies, attributed to diverse datasets, machine learning models (traditional vs. deep learning), cross-validation techniques, sample sizes, and publication dates.
- Cross-validation methods, such as k-fold, can overestimate accuracy compared to independent sample validation.
Conclusions:
- While sMRI-based models demonstrate potential for classifying AD from NC, considerable heterogeneity exists.
- Factors such as varied methodologies and data sources present challenges for developing clinically applicable early AD diagnostic systems.
- Further research and standardization are necessary to bridge the gap between research findings and clinical practice in AD diagnosis.


